The RetiAF score demonstrated a robust performance across multi-ethnic, multi-center datasets, and the potentials of non-invasive retinal imaging as a scalable tool for AF and cardiovascular risk assessment, offering a promising alternative for large-scale screenings and personalized interventions.
Abstract
Atrial fibrillation (AF), a common cardiac arrhythmia, presents significant challenges for early detection and management due to its asymptomatic and paroxysmal characteristics. In this study, we introduce the RetiAF score, a multimodal foundation-model-based biomarker derived from retinal fundus images for early detection of AF. We identified that the RetiAF score demonstrated a robust performance across multi-ethnic, multi-center datasets, achieving AUROCs of 0.8610 and 0.8019 on the UK Biobank (UKBB) development and internal testing datasets, and an AUROC of 0.7803 on an external dataset acquired in Shanghai, China. In addition, we identified that the RetiAF score consistently outperformed the traditional risk scores such as CHARGE-AF (AUROC: 0.7553) and C2HEST (AUROC: 0.7246) for the UKBB internal testing dataset. Multivariable logistic regression and propensity score analyses further demonstrated that the RetiAF score was independently associated with AF risk (p < 0.001). When stratified by higher C2HEST scores (≥3), the RetiAF score achieved an AUROC of 0.9619, highlighting its potential for identifying high-risk patients before the clinical onset of AF. The multimodal hybrid version of RetiAF (Hybrid_RetiAF) score, which incorporated clinical features (e.g., Age, BMI, etc) into the deep learning model, further enhanced predictive performance and achieved AUROCs of 0.8924 and 0.8381 on the UKBB Cohorts. As a secondary exploratory analysis, we evaluated whether RetiAF-derived scores were associated with chronic ischemic heart disease in UKBB, suggesting shared cardio-retinal risk information. These findings underscore the potentials of non-invasive retinal imaging as a scalable tool for AF and cardiovascular risk assessment, offering a promising alternative for large-scale screenings and personalized interventions.
The EHR-based machine learning model, FIND-AF 2.0, identifies a high-risk subpopulation for AF diagnosis among patients at elevated risk of stroke and could enable scalable, EHR-driven, risk-guided AF screening.
R. Nadarajah, Jianhua Wu, A. Wahab et al.· Circulation· 0 citations
External validation of the GLORIA-AF Stroke Weighted Risk Score supports its transportability and potential adjunctive role in guideline-directed thromboembolic risk assessment and generally greater net benefit than CHA2DS2-VA.
A predictive model incorporating VEGF alongside clinical factors provides improved risk stratification and highlights the importance of endothelial dysfunction in ACI pathogenesis and support the integration of biomarkers into clinical decision-making.
Si-Liang Han, Chunhong Chen, Zhe Wang et al.· Frontiers in Cardiovascular...· 0 citations
A comprehensive overview of current AI applications in AF management, including early detection, risk stratification, cardiovascular imaging, clinical decision support, and interventional electrophysiology is provided.
V. Cicek, M. Hayıroğlu, Vanshali Sharma et al.· Balkan Medical Journal· 0 citations
In conclusion, AI-derived risk estimates improved physician risk discrimination in a structured simulated survey, particularly in non-specialist settings, supporting their potential role as a digital decision-support tool.
Yeji Kim, Bogeun Kim, J. Yoon et al.· npj Digital Medicine· 0 citations
The findings suggest that multidomain integration provides an interpretable proof-of-concept framework for characterizing heterogeneous atrial remodeling and identifying potentially vulnerable substrate phenotypes.
Leire Moriones, Blas Echebarria, Javier Ibero et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.